For context, a 10 mmHg reduction in systolic blood pressure is associated with approximately 20% lower risk of major cardiovascular events
There was no plateau, and in fact it appears longer term trials will probably easily clear 20% weight loss, especially if metformin and/or SGLT2i medications are added on as these can both add another 2-3% extra weight loss when combined with a GLP-1 medication
Gastaldelli A, Gaggini M, Daniele G, Ciociaro D, Cersosimo E, Tripathy D, et al
People typically begin to see weight loss results within the first 412 weeks of treatment, including a reduction in appetite, fewer cravings, and less food noise
While direct comparison is complicated by different trial designs and durations, the available data allows reasonable estimates
doi:10.1016/S0196-9781(97)00001-6